Balance Sheet (USD $)	Apr. 30, 2012	Jul. 31, 2011
Current assets
Cash and cash equivalents	$ 25,000	$ 51,789
Total current assets	25,000	51,789
Other assets
Patents and patent applications (net of accumulated amortizaton)	25,164	25,926
Total assets	50,164	77,715
Liabilities
Accounts payable and accrued liabilities	111,226	104,136
Accrued salaries and wages	177,600	4,127
Due to related party	126,412	307,969
Convertible notes payable	100,000
Derivative liability	18,603
Total liabilities	533,841	416,232
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 117,340,901 shares issued and outstanding at April 30, 2012 and 76,976,333 shares issued and outstanding at July 31, 2011	117,341	76,976
Additional paid-in capital	21,663,898	11,092,214
Accumulated deficit during the development stage	(22,264,916)	(11,507,707)
Total stockholders' equity (deficit)	(483,677)	(338,517)
Total liabilities and stockholders' equity(deficit)	$ 50,164	$ 77,715